Astrana Health, Inc. (NASDAQ:ASTH) Short Interest Update

Astrana Health, Inc. (NASDAQ:ASTH) saw a large decline in short interest in December. As of December 31st, there was short interest totalling 1,490,000 shares, a decline of 8.6% from the December 15th total of 1,630,000 shares. Based on an average daily trading volume, of 303,600 shares, the days-to-cover ratio is currently 4.9 days. Currently, 4.2% of the shares of the stock are short sold.

Analysts Set New Price Targets

A number of research firms have commented on ASTH. TD Cowen began coverage on shares of Astrana Health in a research report on Monday, October 14th. They set a “buy” rating and a $66.00 price target on the stock. BTIG Research boosted their target price on shares of Astrana Health from $60.00 to $70.00 and gave the stock a “buy” rating in a report on Thursday, October 3rd. Robert W. Baird boosted their target price on shares of Astrana Health from $67.00 to $86.00 and gave the stock an “outperform” rating in a report on Wednesday, November 13th. Macquarie upgraded shares of Astrana Health to a “hold” rating in a report on Monday, December 16th. Finally, Truist Financial dropped their target price on shares of Astrana Health from $59.00 to $50.00 and set a “buy” rating on the stock in a report on Monday, January 13th. Two research analysts have rated the stock with a hold rating, six have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, Astrana Health presently has an average rating of “Moderate Buy” and a consensus price target of $63.67.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in ASTH. Central Pacific Bank Trust Division purchased a new position in Astrana Health during the third quarter valued at approximately $160,000. SG Americas Securities LLC purchased a new position in Astrana Health during the third quarter valued at approximately $680,000. Granite Bay Wealth Management LLC purchased a new position in Astrana Health during the third quarter valued at approximately $290,000. Handelsbanken Fonder AB purchased a new position in Astrana Health during the third quarter valued at approximately $492,000. Finally, GAMMA Investing LLC purchased a new position in Astrana Health during the third quarter valued at approximately $34,000. 52.77% of the stock is owned by hedge funds and other institutional investors.

Astrana Health Stock Up 5.4 %

ASTH stock opened at $35.17 on Friday. Astrana Health has a 52-week low of $29.08 and a 52-week high of $63.20. The company’s 50 day simple moving average is $37.26 and its 200-day simple moving average is $46.67. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.91 and a quick ratio of 1.91. The firm has a market capitalization of $1.98 billion, a P/E ratio of 27.05, a P/E/G ratio of 1.12 and a beta of 1.20.

Astrana Health (NASDAQ:ASTH) last released its quarterly earnings results on Thursday, November 7th. The company reported $0.33 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.33. Astrana Health had a net margin of 3.63% and a return on equity of 9.37%. The business had revenue of $478.71 million for the quarter, compared to analyst estimates of $462.01 million. During the same quarter in the previous year, the business earned $0.47 earnings per share. As a group, equities research analysts anticipate that Astrana Health will post 1.16 EPS for the current year.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.